The DOI matches its Crossref record; 365 of the 365 references it cites were found in a registry or an index.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder
Open accessAbstract
OBJECTIVES: These guidelines are based on a first edition that was published in 2004, and have been edited and updated with the available scientific evidence up to October 2012. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the long-term treatment of bipolar disorder in adults. METHODS: Material used for these guidelines are based on a systematic literature search using various data bases. Their scientific rigor was categorised into six levels of evidence (A-F) and different grades of recommendation to ensure practicability were assigned. RESULTS: Maintenance trial designs are complex and changed fundamentally over time; thus, it is not possible to give an overall recommendation for long-term treatment. Different scenarios have to be examined separately: Prevention of mania, depression, or an episode of any polarity, both in acute responders and in patients treated de novo. Treatment might differ in Bipolar II patients or Rapid cyclers, as well as in special subpopulations. We identified several medications preventive against new manic episodes, whereas the current state of research into the prevention of new depressive episodes is less satisfactory. Lithium continues to be the substance with the broadest base of evidence across treatment scenarios. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2004, there are still areas of uncertainty, especially the prevention of depressive episodes and optimal long-term treatment of Bipolar II patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Another methodological limitation is sponsor bias (Lexchin et al 2003;Perlis et al 2005;Lexchin and Light 2006;Heres et al 2006) inherent in most single studies on which the guidelines are based.”
BackgroundFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“In the original proposal by Frank et al., developed for major depression (Frank et al 1991b), recovery was achieved when there was remission even in the absence of any treatment.”
Manic-Depressive Insanity and Paranoia.
(1921) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1921.02630330070026 · Cited by 1,573
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Self-citationYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Self-citationTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationMortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881 · cited 1×
“Finally, bipolar disorder is associated with an excess mortality including an increased risk of suicide (Angst et al 2002;Licht et al 2008).”
BackgroundMorrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 877
Self-citationBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationOmega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Lieberman, J. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.361 · Cited by 801
Relapse and impairment in bipolar disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1635 · Cited by 762
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
Self-citationRummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 675
Geddes, J. R., Burgess, S., Hawton, K., Jamison, K., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.217 · Cited by 661
Self-citationThe enduring psychosocial consequences of mania and depression
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.5.720 · Cited by 658
Bowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Self-citationCalabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635
Self-citationCipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1805 · Cited by 617
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608
Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J. A., Herings, R. M. C., & Mann, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030454 · Cited by 605
Functional outcome in bipolar disorder: the role of clinical and cognitive factors
Martinez‐Aran, A., Vieta, E., Torrent, C., Sanchez‐Moreno, J., Goikolea, J., Salamero, M., Malhi, G., Gonzalez‐Pinto, A., Daban, C., Alvarez‐Grandi, S., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00327.x · Cited by 585
Self-citation(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1 · Cited by 583
Goodwin, G. M., Bowden, C. L., Calabrese, J. R., Grunze, H., Kasper, S., White, R., Greene, P., & Leadbetter, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0321 · Cited by 581 · cited 3×
“…publisher website: http://informahealthcare.com Date deposited: 28th June 2013 [made available 1st April 2014] Version of file: Author final This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License ePrints – Newcastle University ePrints http://eprint.ncl.ac.uk”
BackgroundMethodInfluentialSelf-citationBaastrup, P. C. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730200030005 · Cited by 570
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Self-citationLithium toxicity profi le: a systematic review and meta-analysis
McKnight, R. F., Budge, K., Ba, S., Goodwin, G. M., Geddes, J. R., & Adida, M. (2012) · Cited by 544
Self-citationSuicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Goodwin, F. K. (2003) · JAMA · doi:10.1001/jama.290.11.1467 · Cited by 531
Tohen, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.220 · Cited by 524
Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
Tohen, M., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., Yatham, L. N., Malhi, G. S., Calabrese, J. R., Nolen, W. A., Vieta, E., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00726.x · Cited by 513
Self-citationBaastrup, P. C., Poulsen, J. C., Schou, M., Thomsen, K., & Amdisen, A. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92870-9 · Cited by 505
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Self-citationLithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Self-citationThe McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence
Tohen, M., Zarate, C. A., Hennen, J., Khalsa, H.-M. K., Strakowski, S. M., Gebre-Medhin, P., Salvatore, P., & Baldessarini, R. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2099 · Cited by 471
Tohen, M., Chengappa, K. N. R., Suppes, T., Zarate, C. A., Calabrese, J. R., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Baker, R. W., Risser, R. C., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.62 · Cited by 463
Self-citationHeres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
Fagiolini, A., Frank, E., Scott, J. A., Turkin, S., & Kupfer, D. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00234.x · Cited by 449
Prien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448 · cited 2×
“We identified only one study in Bipolar I patients where a antidepressant was used a priori as preventive treatment in euthymic patients (Prien et al 1973b).”
BackgroundResultGoodwin, G., & Consensus Group of the British Association for Psychopharmacology (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102919 · Cited by 444
Self-citationIs Response to Prophylactic Lithium a Familial Trait?
Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1013 · Cited by 438 · cited 2×
“_____________________ Insert Table 1 about here _____________________ Less formalistic, but probably more informative is an approach introduced by Grof et al (Grof et al 2002), the so called Alda scale.”
BackgroundSuicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419
Self-citationAntipsychotic medications: metabolic and cardiovascular risk.
Newcomer, J. W. (2007) · PubMed · Cited by 416
Obesity as a Correlate of Outcome in Patients With Bipolar I Disorder
Fagiolini, A., Kupfer, D. J., Houck, P. R., Novick, D. M., & Frank, E. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.112 · Cited by 405
Rush, A. J., Sackeim, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Davis, S. M., Lavori, P., Howland, R., Kling, M. A., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.024 · Cited by 400
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
Self-citationManagement of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394
Roy‐Byrne, P., Post, R. M., Uhde, T. W., Porcu, T., & Davis, D. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb10510.x · Cited by 391
(1957) · The Lancet · doi:10.1016/s0140-6736(57)91352-1 · Cited by 391
Young, A. H., McElroy, S. L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., & EMBOLDEN I (Trial 001) Investigators (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04995gre · Cited by 390
The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
Wasserman, D., Rihmer, Z., Rujescu, D., Sarchiapone, M., Sokolowski, M., Titelman, D., Zalsman, G., Zemishlany, Z., & Carli, V. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.003 · Cited by 390
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs, G. S., PRINTZ, D. J., Kahn, D. A., Carpenter, D. P., & Docherty, J. P. (2000) · PubMed · Cited by 390
Keck, P. E., Versiani, M., Potkin, S., West, S. A., Giller, E., Ice, K., & the Ziprasidone in Mania Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.741 · Cited by 369
Tohen, M., Greil, W., Calabrese, J. R., Sachs, G. S., Yatham, L. N., Oerlinghausen, B. M., Koukopoulos, A., Cassano, G. B., Grunze, H., Licht, R. W., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1281 · Cited by 365
Self-citationEarly-Onset Bipolar Disorder and Treatment Delay Are Risk Factors for Poor Outcome in Adulthood
Post, R. M., Leverich, G. S., Kupka, R. W., Keck, P. E., McElroy, S. L., Altshuler, L. L., Frye, M. A., Luckenbaugh, D. A., Rowe, M., Grunze, H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04994yel · Cited by 360
Self-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902823202 · Cited by 346
Self-citationAntiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., Altshuler, L., Zajecka, J., Schuh, L. M., Risser, R. C., Brown, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1263 · Cited by 342
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Maser, J., Rice, J. A., Solomon, D. A., & Keller, M. B. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00324-5 · Cited by 339
Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine: An Update
Spina, E., Pisani, F., & Perucca, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00004 · Cited by 331
McElroy, S. L., Weisler, R. H., Chang, W., Olausson, B., Paulsson, B., Brecher, M., Agambaram, V., Merideth, C., Nordenhem, A., Young, A. H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04942gre · Cited by 328
Bonnín, C. M., Martínez-Arán, A., Torrent, C., Pacchiarotti, I., Rosa, A. R., Franco, C., Murru, A., Sanchez-Moreno, J., & Vieta, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.014 · Cited by 328
Self-citationTohen, M., Chengappa, K. N. R., Suppes, T., Baker, R. W., Zarate, C. A., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Ghaemi, S. N., Feldman, P. D., et al. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.4.337 · Cited by 326
Self-citationStones in the kidney and ureter.
Hellström, J. (1948) · PubMed · Cited by 323
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Angst, J., Angst, F., Gerber-Werder, R., & Gamma, A. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929488 · Cited by 318
Tohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317
Self-citationPregnancy Outcome of Women Using Atypical Antipsychotic Drugs: A Prospective Comparative Study
McKenna, K., Koren, G., Tetelbaum, M., Wilton, L., Shakir, S., Diav-Citrin, O., Levinson, A., Zipursky, R. B., & Einarson, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0406 · Cited by 312
Adjunctive Psychotherapy for Bipolar Disorder: State of the Evidence
Miklowitz, D. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040488 · Cited by 311 · cited 1×
“…into account (“ Recommendation grade (RG)”) Although this guideline is focussing on biological treatment modalities, the authors clearly recognize the importance of and evidence for psychotherapies and psychoeducation as additional therapies (Miklowitz 2008;Beynon et al 2008;Vieta et al 2009c).”
BackgroundComparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder
Denicoff, K. D., Smith-Jackson, E. E., Disney, E. R., Ali, S. O., Leverich, G. S., & Post, R. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1102 · Cited by 311
The course of affective disorders: II. Typology of bipolar manic-depressive illness
Angst, J. (1978) · Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie · doi:10.1007/bf00344125 · Cited by 310
Frangou, S., Lewis, M., & McCrone, P. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.46 · Cited by 309
Clinical and therapeutic implications of predominant polarity in bipolar disorder
Colom, F., Vieta, E., Daban, C., Pacchiarotti, I., & Sánchez-Moreno, J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.032 · Cited by 301
Self-citationFernandes, P. P., Ramaswamy, S., Marcil, W., & Petty, F. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60649-x · Cited by 294
Cognitive impairment in the euthymic phase of affective disorder
KESSING, L. V. (1998) · Psychological Medicine · doi:10.1017/s0033291798006862 · Cited by 291
Keck, P. E., Calabrese, J. R., McQuade, R. D., Carson, W. H., Carlson, B. X., Rollin, L. M., Marcus, R. N., Sanchez, R., & Aripiprazole Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0414 · Cited by 290
The use of Lithium Salts in Affective Disorders
Hartigan, G. P. (1963) · British Journal of Psychiatry · doi:10.1192/bjp.109.463.810 · Cited by 290
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Self-citationPrien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750330035006 · Cited by 287
Neurocognitive impairment in bipolar disorder patients: functional implications
Wingo, A. P., Harvey, P. D., & Baldessarini, R. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00665.x · Cited by 274
Defining remission by cut off score on the MADRS: selecting the optimal value
Hawley, C. J., Gale, T. M., & Sivakumaran, T. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00451-7 · Cited by 266
Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study
Greil, W., Ludwig-Mayerhofer, W., Erazo, N., Schöchlin, C., Schmidt, S., Engel, R. R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., et al. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)01427-9 · Cited by 261
Histone deacetylase as a therapeutic target
Krämer, O. H., Göttlicher, M., & Heinzel, T. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00438-6 · Cited by 257
Olanzapine Versus Divalproex in the Treatment of Acute Mania
Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., Ketter, T. A., Milton, D. R., Risser, R., Gilmore, J. A., Breier, A., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1011 · Cited by 256
Calabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2152 · Cited by 252
Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
Yildiz, A., Vieta, E., Leucht, S., & Baldessarini, R. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.192 · Cited by 252
Self-citationHyponatremia Associated with Carbamazepine and Oxcarbazepine Therapy: A Review
Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02930.x · Cited by 250
Yatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248
Self-citationvan der Loos, M. L. M., Mulder, P. G. H., Hartong, E. G. T. M., Blom, M. B. J., Vergouwen, A. C., de Keyzer, H. J. U. E. M., Notten, P. J. H., Luteijn, M. L., Timmermans, M. A., Vieta, E., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04152 · Cited by 243
Self-citationMaj, M., Pirozzi, R., Magliano, L., & Bartoli, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.30 · Cited by 242
Keck, P. E., & Calabrese, J. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1003 · Cited by 238
Keck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234
Self-citationSuppes, T., Vieta, E., Liu, S., Brecher, M., Paulsson, B., & Trial 127 Investigators (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020189 · Cited by 230
Self-citationVieta, E., Suppes, T., Eggens, I., Persson, I., Paulsson, B., & Brecher, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.001 · Cited by 227
Self-citationScott, J., Colom, F., & Vieta, E. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006900 · Cited by 227
Self-citationOkuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A., & Watanabe, S. (1981) · Psychopharmacology · doi:10.1007/bf00431111 · Cited by 224
López‐Jaramillo, C., Lopera‐Vásquez, J., Gallo, A., Ospina‐Duque, J., Bell, V., Torrent, C., Martínez‐Arán, A., & Vieta, E. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00835.x · Cited by 224
Self-citationAngst, J., & Preisig, M. (1995) · PubMed · Cited by 223
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Altshuler, L. L., Post, R. M., Black, D. O., Keck, P. E., Nolen, W. A., Frye, M. A., Suppes, T., Grunze, H., Kupka, R. W., Leverich, G. S., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1009 · Cited by 216
Self-citationRecurrence in affective disorder: I. Case register study
Kessing, L. V., Bolwig, T. G., Andersen, P. K., & Mortensen, P. B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.23 · Cited by 214
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090053011 · Cited by 212 · cited 1×
“When investigating Bipolar II patients, Kane at al. found no advantage of imipramine over placebo (Kane et al 1982).”
BackgroundPredicting medication adherence in severe mental disorders
Adams, J., & Scott, J. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.90061.x · Cited by 208
Effect of Prophylactic Treatment on Suicide Risk in Patients with Major Affective Disorders
Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A., & Greil, W. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979553 · Cited by 205
Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
Quiroz, J. A., Yatham, L. N., Palumbo, J. M., Karcher, K., Kushner, S., & Kusumakar, V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.015 · Cited by 200 · cited 1×
“In combination with lithium, imipramine was also not more effective than lithium monotherapy (Quitkin et al 1978;Quitkin et al 1981).”
BackgroundBipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00561.x · Cited by 200
Self-citationStahl, S. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0202 · Cited by 199
Use of topiramate, a new anti-epileptic as a mood stabilizer
Marcotte, D. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00110-4 · Cited by 197
Frye, M. A., Helleman, G., McElroy, S. L., Altshuler, L. L., Black, D. O., Keck, P. E., Nolen, W. A., Kupka, R., Leverich, G. S., Grunze, H., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030322 · Cited by 194
Self-citationAssociation Between Cognitive Functioning and Employment Status of Persons With Bipolar Disorder
Dickerson, F. B., Boronow, J. J., Stallings, C. R., Origoni, A. E., Cole, S., & Yolken, R. H. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.1.54 · Cited by 192
Suicidal risk in bipolar I disorder patients and adherence to long‐term lithium treatment
Gonzalez‐Pinto, A., Mosquera, F., Alonso, M., López, P., Ramírez, F., Vieta, E., & Baldessarini, R. J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00368.x · Cited by 189
Self-citationPolarity index of pharmacological agents used for maintenance treatment of bipolar disorder
Popovic, D., Reinares, M., Goikolea, J. M., Bonnin, C. M., Gonzalez-Pinto, A., & Vieta, E. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.008 · Cited by 187
Self-citationSmith, L. A., Cornelius, V., Warnock, A., Bell, A., & Young, A. H. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00490.x · Cited by 186
Renal failure occurs in chronic lithium treatment but is uncommon
Bendz, H., Schön, S., Attman, P.-O., & Aurell, M. (2010) · Kidney International · doi:10.1038/ki.2009.433 · Cited by 183
Ernst, C. L., & Goldberg, J. F. (2002) · PubMed · Cited by 181
Goodwin, G. M., Martinez-Aran, A., Glahn, D. C., & Vieta, E. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.005 · Cited by 180
Self-citationTherapeutic drug monitoring of old and newer anti-epileptic drugs
Neels, H. M., Sierens, A. C., Naelaerts, K., Scharpé, S. L., Hatfield, G. M., & Lambert, W. E. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.245 · Cited by 178
Longitudinal Course of Bipolar I Disorder: Duration of Mood Episodes
Solomon, D. A., Leon, A. C., Coryell, W. H., Endicott, J., Li, C., Fiedorowicz, J. G., Boyken, L., & Keller, M. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.15 · Cited by 178
Macfadden, W., Alphs, L., Haskins, J. T., Turner, N., Turkoz, I., Bossie, C., Kujawa, M., & Mahmoud, R. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00761.x · Cited by 178
Long‐term antidepressant treatment in bipolar disorder: meta‐analyses of benefits and risks
Ghaemi, S. N., Wingo, A. P., Filkowski, M. A., & Baldessarini, R. J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01257.x · Cited by 173
Beynon, S., Soares‐Weiser, K., Woolacott, N. F., Duffy, S., & Geddes, J. R. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037887 · Cited by 173
Lamotrigine: A Review of its Use in Bipolar Disorder
Goldsmith, D. R., Wagstaff, A. J., Ibbotson, T., & Perry, C. M. (2003) · Drugs · doi:10.2165/00003495-200363190-00009 · Cited by 171
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Suppes, T., Altshuler, L. L., Keck, P. E., Frye, M. A., Denicoff, K. D., Grunze, H., Leverich, G. S., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1273 · Cited by 171
Self-citationBipolar Disorder — A Focus on Depression
Frye, M. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1000402 · Cited by 170
Weisler, R. H., Nolen, W. A., Neijber, A., Hellqvist, Å., Paulsson, B., & Trial 144 Study Investigators (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06878 · Cited by 169
Rapid and Non-Rapid Cycling Bipolar Disorder: A Meta-Analysis of Clinical Studies
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Leverich, G. S., & Nolen, W. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1213 · Cited by 168 · cited 1×
“…separation as separate subcategories (Judd et al 2003;Vieta and Suppes 2008) and while it is becoming apparent that to define rapid cycling in a separate category is to some degree artificial (Kupka et al 2003;Kupka et al 2005) it is still consistently applied in prophylactic treatment trials.”
BackgroundLithium: Still a Major Option in the Management of Bipolar Disorder
Licht, R. W. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00260.x · Cited by 168
Self-citationEfficacy and Safety of Fluoxetine in Treating Bipolar II Major Depressive Episode
Amsterdam, J. D., Garcia-Espana, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., Schweizer, E., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00003 · Cited by 167 · cited 1×
“Amsterdam et al (Amsterdam et al 1998) compared fluoxetine in unipolar depressed with fluoxetine in bipolar II depressed patients in acute and long-term treatment (up to one year).”
BackgroundAnticonvulsants in affective disorders
Emrich, H. M., 大熊, 輝., & Müller, A. A. (1984) · Excerpta Medica eBooks · Cited by 165
Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression
Gyulai, L., Bowden, C. L., McElroy, S. L., Calabrese, J. R., Petty, F., Swann, A. C., Chou, J. C.-Y., Wassef, A., Risch, C. S., Hirschfeld, R. M. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300190 · Cited by 165
Self-citationOquendo, M. A., Galfalvy, H. C., Currier, D., Grunebaum, M. F., Sher, L., Sullivan, G. M., Burke, A. K., Harkavy-Friedman, J., Sublette, M. E., Parsey, R. V., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010163 · Cited by 165
Lithium-discontinuation-induced refractoriness: preliminary observations
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.12.1727 · Cited by 163
Goodwin, G. M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.149 · Cited by 162
Self-citationStabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature
Ketter, T., & Calabrese, J. R. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0210 · Cited by 161
Vieta, E., T’joen, C., McQuade, R. D., Carson, W. H., Marcus, R. N., Sanchez, R., Owen, R., & Nameche, L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101560 · Cited by 161
Self-citationPotkin, S. G., Keck, P. E., Segal, S., Ice, K., & English, P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169068.34322.70 · Cited by 159
Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders
Melia, P. I. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.116.535.621 · Cited by 159
STALLONE, F., SHELLEY, E., MENDLEWICZ, J., & FIEVE, R. R. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.9.1006 · Cited by 159
Grunze, H., Kasper, S. F., Goodwin, G. M., Bowden, C. L., ller, H.-J. R. M., & WFSBP Task Force on Treatment Guide (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029924 · Cited by 159
Self-citationRelationship Between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder
Gibbons, R. D., Hur, K., Brown, C. H., & Mann, J. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.159 · Cited by 156
Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the Literature
Petrides, G., Tobias, K. G., Kellner, C. H., & Rudorfer, M. V. (2011) · Neuropsychobiology · doi:10.1159/000328943 · Cited by 156
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications
Baldessarini, R. J., Tondo, L., & Viguera, A. C. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10106.x · Cited by 156
Flupenthixol decanoate in recurrent manic‐depressive illness: A COMPARISON WITH LITHIUM
Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjærde, O., Pedersen, V., Schou, M., & Aaskoven, O. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00778.x · Cited by 155
The impact of staging bipolar disorder on treatment outcome of family psychoeducation
Reinares, M., Colom, F., Rosa, A. R., Bonnín, C. D. M., Franco, C., Solé, B., Kapczinski, F. P., & Vieta, E. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.009 · Cited by 155
Self-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., LICHT, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.9.4.500 · Cited by 153
Self-citationLithium-associated clinical hypothyroidism: Prevalence and risk factors
Johnston, A. M., & Eagles, J. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.4.336 · Cited by 152
Lithium and the Kidney: An Updated Review
Gitlin, M. J. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00004 · Cited by 151
Amsterdam, J. D., & Shults, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020284 · Cited by 149
Antidepressant Discontinuation in Bipolar Depression
Ghaemi, S. N., Ostacher, M. J., El‐Mallakh, R. S., Borrelli, D. J., Baldassano, C. F., Kelley, M. E., Filkowski, M. M., Hennen, J. A., Sachs, G. S., Goodwin, F. K., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04909gre · Cited by 148
Goldberg, J. F., Brooks, J. O., Kurita, K., Hoblyn, J. C., Ghaemi, S. N., Perlis, R. H., Miklowitz, D. J., Ketter, T. A., Sachs, G. S., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04301 · Cited by 148
Carbamazepine vs Lithium in the Treatment and Prophylaxis of Mania
Lusznat, R. M., Murphy, D. P., & Nunn, C. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.2.198 · Cited by 146
Atypical Depression: A Valid Subtype?
Parker, G. B., & Thase, M. E. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0307e08 · Cited by 145
Zarate, C. A., & Tohen, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.169 · Cited by 144
Bowden, C. L., Vieta, E., Ice, K. S., Schwartz, J. H., Wang, P. P., & Versavel, M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05482yel · Cited by 144
Self-citationA controlled evaluation of lithium prophylaxis in affective disorders
Cundall, R., Brooks, P. W., & Murray, L. G. (1972) · Psychological Medicine · doi:10.1017/s0033291700042616 · Cited by 144
Body mass index versus waist circumference as predictors of mortality in Canadian adults
Staiano, A. E., Reeder, B. A., Elliott, S., Joffres, M. R., Pahwa, P., Kirkland, S. A., Paradis, G., & Katzmarzyk, P. T. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.268 · Cited by 143
Prophylactic Efficacy of Lithium Versus Carbamazepine in Treatment-Naive Bipolar Patients
Hartong, E. G. T. M., Moleman, P., Hoogduin, C. A. L., Broekman, T. G., Nolen, W. A., & LitCar Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0206 · Cited by 143
Placidi, G. F., Lenzi, A., Lazzerini, F., Cassano, G., & Akiskal, H. S. (1986) · PubMed · Cited by 142
Effects of chronic lithium treatment on renal function
Tredget, J., Kirov, A., & Kirov, G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.018 · Cited by 140
Bond, D. J., Noronha, M. M., Kauer‐Sant’Anna, M., Lam, R. W. M., & Yatham, L. N. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1009 · Cited by 139
Marcus, R. N., Khan, A., Rollin, L., Morris, B. A., Timko, K., Carson, W. H., & Sanchez, R. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00898.x · Cited by 139
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients
Fieve, R. R., Kumbaraci, T., & Dl, D. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.8.925 · Cited by 137
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
Coxhead, N., Silverstone, T., & Cookson, J. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01453.x · Cited by 134
PROPHYLACTIC LITHIUM IN RECURRENT AFFECTIVE DISORDERS
Myers, E. D. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91009-4 · Cited by 133
Vieta, E., Montgomery, S., Sulaiman, A. H., Cordoba, R., Huberlant, B., Martinez, L., & Schreiner, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.03.004 · Cited by 130
Self-citationIs clozapine a mood stabilizer?
Zarate, C. A., Tohen, M. F., Banov, M. D., Weiss, M. K., & Cole, J. O. (1995) · PubMed · Cited by 130
Lithium: Clinical Considerations in Internal Medicine
Freeman, M. P., & Freeman, S. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.003 · Cited by 128
Vernon, A. C., Natesan, S., Crum, W. R., Cooper, J. D., Modo, M., Williams, S., & Kapur, S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.004 · Cited by 127
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 127
Self-citationZhang, X., Heng, X., Li, T., Li, L., Yang, D., Zhang, X., Du, Y., Doody, R. S., & Le, W. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101875 · Cited by 126
Safety of Haloperidol and Penfluridol in Pregnancy
Diav‐Citrin, O., Shechtman, S., Ornoy, S., Arnon, J., Schaefer, C., Garbis, H., Clementi, M., & Ornoy, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0307 · Cited by 126
LITHIUM MAINTENANCE TREATMENT OF MANIC‐MELANCHOLIC PATIENTS: ITS ROLE IN THE DAILY ROUTINE
Bech, P., Vendsborg, P. B., & Rafaelsen, O. J. (1976) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1976.tb00060.x · Cited by 125
Functional impairment in patients with mania: baseline results of the EMBLEM study
GOETZ, I. A., Tohen, M. F., Reed, C. C., Lorenzo, M. M., Vieta, E., & the EMBLEM Advisory Board (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00325.x · Cited by 125
Self-citationAllen, M. H., Hirschfeld, R. M. A., Wozniak, P. J., Baker, J. D., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.272 · Cited by 124
Self-citationPharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G. S. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.5.660 · Cited by 123
Zimmerman, M., Martinez, J. A., Attiullah, N., Friedman, M., Toba, C., Boerescu, D. A., & Rahgeb, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07203 · Cited by 122
Excellent lithium responders have normal cognitive functions and plasma BDNF levels
RYBAKOWSKI, J. K., & Suwalska, A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000404 · Cited by 120
Prediction of relapse in recurrent affective disorder.
Zis, A. P., Grof, P., Webster, M. H., & Fk, G. (1980) · PubMed · Cited by 119
Lake, C. R., & Hurwitz, N. G. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281a305ab · Cited by 117
Severus, W. E., Littman, A. B., & Stoll, A. L. (2001) · Harvard Review of Psychiatry · doi:10.1080/10673220127910 · Cited by 116
Vieta, E., Günther, O., Locklear, J. C., Ekman, M., Miltenburger, C., Chatterton, M. L., Åström, M., & Paulsson, B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000885 · Cited by 116
Self-citationAsenapine versus olanzapine in acute mania: a double‐blind extension study
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L. D., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00749.x · Cited by 115
Early onset of lithium prophylaxis as a predictor of good long-term outcome
Franchini, L., Zanardi, R., Smeraldi, E., & Gasperini, M. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050091 · Cited by 113
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T. M., Keck, P. E., McElroy, S. L., Leverich, G. S., Luckenbaugh, D. A., Rowe, M., Pizzarello, S., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04811yel · Cited by 113
Self-citation
Research works printed but not linked: 52
- Abou-Auda HS, 2008, Bipolar Disord, 10, 369, 10.1111/j.1399-5618.2007.00549.x · doi:10.1111/j.1399-5618.2007.00549.x
- Agarkar S, 2011, J Neuropsychiatry Clin Neurosci, 23, 12, 10.1176/jnp.23.2.jnpe12 · doi:10.1176/jnp.23.2.jnpe12
- Anderson J, 2000, J Rheumatol, 27, 540
- Angst J, 1981, Handbook of Biological Psychiatry, 225
- Angst J, 1995, Schweiz Arch Neurol Psychiatr, 146, 17
- Becker D, 2002, Eur Psychiatry, 17, 349, 10.1016/S0924-9338(02)00688-0 · doi:10.1016/s0924-9338(02)00688-0
- Benabarre A, 2009, Actas Esp Psiquiatr, 37, 143
- Bowden CL, 1997, Psychopharmacol Bull, 33, 693
- Bowden CL, 2012, Acta Psychiatry, 64, 1013
- Calabrese J, 2003, J Clin
- Carta MG, 2006, Clin Pract Epidemiol Ment Health, 2, 19, 10.1186/1745-0179-2-19 · doi:10.1186/1745-0179-2-19
- Dunner DL, 1998, J Clin Psychiatry, 59, 48
- Emrich HM, 1992, Prog Neuropsychopharmacol Biol Psychiatry, 16, 691, 10.1016/0278-5846(92)90025-A · doi:10.1016/0278-5846(92)90025-a
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Fitzgerald BJ, 2002, Pharmacotherapy, 22, 1500, 10.1592/phco.22.16.1500.33697 · doi:10.1592/phco.22.16.1500.33697
- Garcia-Lopez A, 2001, Actas Esp Psiquiatr, 29, 327
- Ghaemi SN, 2004, Ann Clin Psychiatry, 16, 69, 10.1080/10401230490453103 · doi:10.1080/10401230490453103
- 10.4088/JCP.08m04301 · DOI
- Goncalves N, 1985, Nervenarzt, 56, 43
- Goodwin FK, 2002, J Clin Psychiatry, 63, 5
- Grande I, 2012, Int J Neuropsychopharmacol, 1
- Greil W, 1999, Int Clin Psychopharmacol, 14, 283, 10.1097/00004850-199914050-00003 · DOI
- Greil W, 1999, Int Clin Psychopharmacol, 14, 277, 10.1097/00004850-199914050-00002 · DOI
- Grunze H, 2004, Valproat bei manisch-depressiven (bipolaren) Erkrankungen
- Harvey PD, 2006, J Clin Psychiatry, 67, 14
- Hayes SG, 1989, J Clin Psychiatry, 50, 35
- Hullin RP, 1972, Lancet i, 1044
- Kessing LV, 2011, J Psychopharmacol
- Lancon C, 1996, Encephale, 22, 468
- Lebowitz BK, 2001, Neuropsychiatry Neuropsychol Behav Neurol, 14, 177
- Moskowitz AS, 1991, J Clin Psychopharmacol, 11, 272, 10.1097/00004714-199108000-00020 · doi:10.1097/00004714-199108000-00020
- Murru A, 2011, Eur Psychiatry
- Nolen WA, 2008, Richtlijn bipolaire stoornissen
- Placidi GF, 1986, J Clin Psychiatry, 47, 490
- Popovic D, 2011, Eur Neuropsychopharmacol
- Puri BK, 1995, Br J Clin Pract, 49, 333, 10.1111/j.1742-1241.1995.tb10004.x · doi:10.1111/j.1742-1241.1995.tb10004.x
- Puzynski S, 1984, Psychopharmacol Bull, 20, 151
- Quitkin FM, 1981, Psychopharmacol Bull, 17, 142
- Riedel M, 2010, Expert Opin Drug Saf, 9, 659, 10.1517/14740338.2010.486787 · doi:10.1517/14740338.2010.486787
- Sachdev PS, 1986, Am J Psychiatry, 143, 942, 10.1176/ajp.143.7.942 · doi:10.1176/ajp.143.7.942
- Sachs GS, 2000, Postgrad Med Spec Report, 1
- Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1
- Singh V, 2012, Bipolar Disord, 14, 13
- Szabo CP, 1993, S Afr Med J, 83, 442
- Vieta E, 2011, New Engl J Med, 364, 1581
- 10.1016/j.jad.2009.02.028 · DOI
- Viguera AC, 2007, J Clin Psychiatry, 68, 29
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Yoshimura R, 2006, Pharmacopsychiatry, 39, 233, 10.1055/s-2006-951386 · doi:10.1055/s-2006-951386
- Young AH, 2012, World J Biol Psychiatry
- Zarate CA, 1995, J Clin Psychiatry, 56, 108
- Zis AP, 1980, Psychopharmacol Bull, 16, 47
Cited by
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality
Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4581 · Cited by 438
“It is recommended to check every 3-6 months” Grunze et al, 2013, pp 186 [18] 7.”
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2013-03-13
- Volume
- 14
- Issue
- 3
- Pages
- 154-219
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2170882187
- Cited by
- 421
- References
- 365
- FWCI
- 31.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.